ReviewJapanese journal of clinical oncology2023

Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance.

Taisuke Araki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.